| Literature DB >> 24715957 |
Alton C Williams1, Marie E McNeely2, Deanna J Greene3, Jessica A Church4, Stacie L Warren5, Johanna M Hartlein6, Bradley L Schlaggar7, Kevin J Black8, Lei Wang9.
Abstract
BACKGROUND: Prior brain imaging and autopsy studies have suggested that structural abnormalities of the basal ganglia (BG) nuclei may be present in Tourette Syndrome (TS). These studies have focused mainly on the volume differences of the BG structures and not their anatomical shapes. Shape differences of various brain structures have been demonstrated in other neuropsychiatric disorders using large-deformation, high dimensional brain mapping (HDBM-LD). A previous study of a small sample of adult TS patients demonstrated the validity of the method, but did not find significant differences compared to controls. Since TS usually begins in childhood and adult studies may show structure differences due to adaptations, we hypothesized that differences in BG and thalamus structure geometry and volume due to etiological changes in TS might be better characterized in children.Entities:
Year: 2013 PMID: 24715957 PMCID: PMC3976104 DOI: 10.12688/f1000research.2-207.v1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Subject characteristics.
| TS group | Control group | |
|---|---|---|
|
| 13 | 16 |
| Age at scan (mean ± sd) | 12.44 ± 2.22 | 12.39 ± 1.92 |
| Sex | 3F/10M | 2F/14M |
| Handedness | 12R/1A | 15R/1L |
| Years since onset of tics ± sd | 4.31 ± 2.69 | NA |
| YGTSS total tic score* ± sd | 19.00 ± 11.66 | NA |
| Number with ADHD diagnosis | 4 | 0 |
| Number with OCD diagnosis | 5 | 0 |
| Number who reported currently taking medication: | ||
| Atypical neuroleptics | 1 | 0 |
| Typical neuroleptics | 1 | 0 |
| Stimulants | 1 | 0 |
| Benzodiazepines | 0 | 0 |
| Selective serotonin reuptake inhibitors | 3 | 0 |
| alpha-2 agonists | 5 | 0 |
| Tricyclic antidepressants | 2 | 0 |
| Tetracyclic antidepressants | 1 | 0 |
| 1st generation antihistamines | 2 | 0 |
| Number who reported past use of medication: | ||
| Atypical neuroleptics | 1 | 0 |
| Typical neuroleptics | 1 | 0 |
| Stimulants | 3 | 0 |
| Benzodiazepines | 1 | 0 |
| Selective serotonin reuptake inhibitors | 1 | 0 |
| alpha-2 agonists | 5 | 0 |
| Tricyclic antidepressants | 0 | 0 |
| Tetracyclic antidepressants | 0 | 0 |
*YGTSS total tic score includes only the motor tic and vocal tic subscores for a maximum of 50 points. R = right-handed, L = left-handed, A = ambidextrous.
Volumes of the structures of interest (mm 3).
| TS (n = 13) | Control (n = 16) | ANCOVA statistics (hemisphere by dx) | ||||||
|---|---|---|---|---|---|---|---|---|
| Mean (std) | [95% CIs] mm 3 | Mean (std) | [95% CIs] mm 3 | F |
| P | ||
| Caudate | L
| 3736 (271)
| [3581, 3890]
| 3667 (270)
| [3528, 3806]
|
|
|
|
| Nucleus accumbens | L
| 460 (46)
| [434, 487]
| 462 (46)
| [438, 485]
|
|
|
|
| Globus pallidus | L
| 1826 (126)
| [1754, 1898]
| 1804 (125)
| [1739, 1868]
|
|
|
|
| Putamen | L
| 5925 (367)
| [5716, 6135]
| 5705 (365)
| [5517, 5893]
|
|
|
|
| Thalamus | L
| 8076 (557)
| [7757, 8394]
| 7931(555)
| [7645, 8217]
|
|
|
|
L = left, R = right, T = total volume. Repeated-measures ANOVA of each structure showed no significant group effect. Further, we found no hemisphere effect or group by hemisphere interactions for any of the structures (age and whole brain volume w/out ventricles as covariates).
Shape comparison of the thalamus and basal ganglia structures (TS vs. control).
| MANCOVA statistics | ||||
|---|---|---|---|---|
| Structure | F |
| P | |
| Nucleus accumbens | L
| 1.63
| 10,17
| 0.18
|
| Caudate | L
| 1.31
| 10,17
| 0.30
|
| Globus pallidus | L
| .231
| 10,17
| 0.99
|
| Putamen | L
| .285
| 10,17
| 0.98
|
| Thalamus | L
| .705
| 10,17
| 0.71
|
L = left, R = right, T = total volume. Multivariate analysis of the first 10 eigenvectors of each structure showed no significant group effect (age as covariate).
Effect sizes.
| Partial η | Cohen’s ƒ 2 | |
|---|---|---|
| Volumes (total structure volumes) | ||
| Caudate | 5.51 × 10 -3 | 5.54 × 10 -3 |
| Nucleus accumbens | 2.77 × 10 -4 | 2.78 × 10 -4 |
| Globus pallidus | 2.94 × 10 -2 | 3.03 × 10 -2 |
| Putamen | 6.79 × 10 -2 | 7.29 × 10 -2 |
| Thalamus | 6.42 × 10 -2 | 6.86 × 10 -2 |
| Volumes (hemisphere * dx effects) | ||
| Caudate | 2.00 × 10 -3 | 2.00 × 10 -3 |
| Nucleus accumbens | 1.22 × 10 -6 | 1.22 × 10 -6 |
| Globus pallidus | 3.00 × 10 -2 | 3.09 × 10 -2 |
| Putamen | 1.90 × 10 -2 | 1.94 × 10 -2 |
| Thalamus | 8.00 × 10 -3 | 8.06 × 10 -3 |
| Shapes (principal components): | ||
| Left | ||
| Caudate | 0.436 | 0.773 |
| Nucleus accumbens | 0.490 | 0.961 |
| Globus pallidus | 0.120 | 0.136 |
| Putamen | 0.144 | 0.168 |
| Thalamus | 0.293 | 0.414 |
| Right | ||
| Caudate | 0.303 | 0.435 |
| Nucleus accumbens | 0.530 | 1.128 |
| Globus pallidus | 0.333 | 0.499 |
| Putamen | 0.303 | 0.435 |
| Thalamus | 0.344 | 0.524 |